Home
Finance & valuation

Finance & valuation

SVB’s collapse is a reminder of how far IP finance still has to travel

Like many others, the bank held thousands of patents as security for loan deals, but almost certainly had no idea of their value – or lack of it

The Market Makers of 2022: top 20 revealed

Marconi's Kasim Alfalahi takes the top spot for Avanci's stellar showing in our countdown of the patent market’s most innovative and influential dealmakers and decision takers

Patent litigation finance skyrockets in past three years

We compiled data from Westfleet Advisors’ annual litigation funding reports to find patent finance shot up by nearly 50% since 2020 – to the benefit of rights holders

Latest content

IPBC Global 2022 approaches sell-out territory

The world’s pre-eminent event focusing on IP value creation takes place in Chicago from 12 to 14 June with over 500 senior delegates set to attend

19 May 2022

Report questions high published royalty rates for voice codec SEPs

Analysis from Stout suggests rates sought by certain Enhanced Voice Services (EVS) patent owners are out of line with the overall 3G/4G/5G FRAND landscape

18 May 2022

Stealthy biotech buys up patent portfolios in string of recent deals

Terran Biosciences has emerged from obscurity to snap up slew of IP rights in the past two months

04 May 2022

Delaware Judge’s litigation finance disclosure may harm plaintiffs, lead to defence settlements

Patent litigators who represent plaintiffs and defendants agree the new standing order favours the defence, but one litigation financier predicts well-financed patentees backed by reputable lenders will get the upper hand

29 April 2022

Dealing with 5G disappointment

The latest wireless standard hasn’t yet found its ‘killer app’ for consumers, and it’s affecting licensing negotiations

23 April 2022

New customer on the secondary patent market: litigation finance companies

Patent brokers and litigation financiers say that over the past year there is a growing trend of lawsuit funders exploring the idea of acquiring their own patent portfolios for monetisation through licensing or litigation

20 April 2022

The advantages of using hedonic regression to measure the value of standardised technologies

Hedonic regression is a dependable and impartial way to estimate the value of a standardised technology. Further, it can be applied to a range of products, especially those with multiple features.

13 April 2022

CRISPR FTO complexities not going anywhere in wake of Broad Institute victory, says IP chief on the CVC side

Following major US CRISPR decision, Michael Arciero, VP of IP at ERS Genomics, tells IAM that tricky patent landscapes are the new normal in biotech

04 April 2022

Five key takeaways from IPBC Europe

Returning from two action-packed days in London, IAM Deputy Editor Adam Houldsworth reflects on the surprising state of corporate UPC strategies, the rise of AI, FRAND fireworks and more

02 April 2022

Highlights from the final day of IPBC Europe 2022

Patent value, IP finance and the challenges of digitisation were just some of the subjects discussed in front of a sell-out audience in London yesterday

31 March 2022

Unlock unlimited access to all IAM content